 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
2/14/23 Flagship VentureLabs IV, LLC SC 13G/A 1:157K Rubius Therapeutics, Inc. Donnelley … Solutions/FA
Flagship V Venturelabs RX Fund, L.P.³
Flagship Ventures Fund IV General Partner LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Fund V, L.P.³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
2/14/22 Flagship Ventures Fd IV Gen’… LLC SC 13G/A 2:176K Rubius Therapeutics, Inc. Donnelley … Solutions/FA
Flagship V Venturelabs RX Fund, L.P.³
Flagship Venturelabs IV LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Fund V, L.P.³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
2/16/21 Flagship Ventures Fd IV Gen’… LLC SC 13G/A 1:166K Rubius Therapeutics, Inc. Donnelley … Solutions/FA
Flagship V Venturelabs RX Fund, L.P.³
Flagship Venturelabs IV LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Fund V, L.P.³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
| ____________ | | ¹ | Filing/Form Type: -U | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
